Therapeutics: NMDA receptor NR2B subtype (GRIN2B; NR2B; GluN2B)

In vitro and mouse studies suggest a pH-sensitive GRIN2B antagonist could improve recovery following stroke. The pH of ischemic and normal brain tissue is 6.9 and 7.6, respectively. Chemical synthesis...